Resources

Publications

Presentations

Meetings/workshops

Publications

PrEP adherence patterns strongly impact individual HIV risk and observed efficacy in randomized clinical trials

Dobromir T. Dimitrov, Benoît R. Mâsse, Deborah Donnell

JAIDS 72(4):444-451 (2016)

Assessing the use of surveillance data to estimate the impact of prevention interventions on HIV incidence in cluster-randomized controlled trials

Mitchell KM, Dimitrov D, Hughes JP, Moore M, Vittinghoff E, Liu A, Cohen MS, Beyrer C, Donnell D, Boily MC

Epidemics

A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population

Dobromir Dimitrov, Hans-Peter Kiem, Keith R. Jerome, Christine Johnston, Joshua T. Schiffer

Scientific Reports. 6:22183 (2016)

The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study

Mitchell KM, Dimitrov D, Silhol R, Geidelberg L, Moore M, Liu A, Beyrer C, Mayer KH, Baral S, Boily MC.

Lancet HIV

How much do we know about drug resistance due to PrEP use? Analysis of experts’ opinion and its influence on the projected public health impact.

Dobromir T. Dimitrov, Marie-Claude Boily, Timothy B. Hallett, Jan Albert, Charles Boucher, John W. Mellors, Deenan Pillay, David A.M.C. van de Vijver

PLoS ONE 11(7): e0158620 (2016)

Assessing the Potential Impact of Disruptions Due to COVID-19 on HIV Among Key and Lower-Risk Populations in the Largest Cities of Cameroon and Benin

Silhol R, Geidelberg L, Mitchell KM, Mishra S, Dimitrov D, Bowring A, Béhanzin L, Guédou F, Diabaté S, Schwartz S, Billong SC, Njindam IM, Levitt D, Mukandavire C, Maheu-Giroux M, Rönn MM, Dalal S, Vickerman P, Baral S, Alary M, Boily MC.

Resources

Publications

PrEP adherence patterns strongly impact individual HIV risk and observed efficacy in randomized clinical trials

Assessing the use of surveillance data to estimate the impact of prevention interventions on HIV incidence in cluster-randomized controlled trials

A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population

The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study

How much do we know about drug resistance due to PrEP use? Analysis of experts’ opinion and its influence on the projected public health impact.

Assessing the Potential Impact of Disruptions Due to COVID-19 on HIV Among Key and Lower-Risk Populations in the Largest Cities of Cameroon and Benin

Presentations

CAHR 2016 – 25th Annual Canadian Conference on HIV/AIDS Research (Winnipeg)

R4P 2018 – HIV Research for Prevention (Madrid)

ISI 2017 – 61st ISI World Statistics Congress (Marrakech)

NHPC 2015 – National HIV Prevention Conference (Atlanta)

IAS 2015 – 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (Vancouver)

CROI 2018 – Conference on Retroviruses and Opportunistic Infections (Boston)

Meetings/workshops

HPTN annual meeting 2017 (Washington DC)

Global HIV Vaccine Enterprise 2017

HPTN annual meeting 2016 (Washington DC)

HPTN annual meeting 2015 (Washington DC)

NIH RAPIDD Workshop (2015) on : integrating mathematical models with the design and analysis of clinical trials to assess the efficacy of disease prevention and control interventions (Seattle)

HPTN annual meeting 2014 (Washington DC)